🇨🇦 Randomization between two referenced treatments in Canada

Randomization between two referenced treatments (Randomization between two referenced treatments) regulatory status in Canada.

Marketing authorisation

Randomization between two referenced treatments in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Randomization between two referenced treatments approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Randomization between two referenced treatments in Canada?

University Hospital, Clermont-Ferrand is the originator. The local marketing authorisation holder may differ — check the official source linked above.